Picture of European Medical Solutions SA logo

ALEMS — European Medical Solutions SA News Story

0.000.00%
be flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapNeutral

Brief: Asit Biotech Publishes Mode Of Action Study Of Gp-ASIT+™ In Journal Of Allergy And Clinical Immunology

Oct 17 (Reuters) - ASIT BIOTECH SA  ASIT.BR :
    * ASIT BIOTECH MODE OF ACTION STUDY OF GP-ASIT+™ FOR GRASS
POLLEN
ALLERGY PUBLISHED IN JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
(JACI)1
    * DATA SHOW HOW GP-ASIT+™, ADMINISTERED IN A PRE-SEASONAL
3-WEEK
TREATMENT, IS ABLE TO RAPIDLY MODULATE CELLULAR RESPONSE AND
INDUCE PRODUCTION OF BLOCKING ANTIBODIES
    * UNDERSTANDING UNDERPINNING MODE OF ACTION OF GP-ASIT+™
VALIDATES
ASIT+™PLATFORM AND ITS POTENTIAL TO GENERATE NEW PRODUCT
CANDIDATES AGAINST OTHER ALLERGIES

Source text for Eikon:  ID:nBw48YgNta 
Further company coverage:  ASIT.BR 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com;))

Recent news on European Medical Solutions SA

See all news